As many are aware, the San Antonio Breast Cancer Symposium (SABCS) 2020 was held virtually this year. There were several presentations about promising treatments for people with MBC, which are presented in my conference recap.
Two of the most encouraging drugs are Tesetaxel, an oral version of intravenous chemotherapy taxanes for which a New Drug Application is expected to be submitted this year, and the oral immunotherapy drug Eganelisib that is being studied among TNBC MBC patients with promising results!
Information from the SABCS 2020 recap has been incorporated in a comprehensive paperback and eBook entitled, “The Insider’s Guide to Metastatic Breast Cancer,” which is also available as a complimentary .pdf. The Guide includes material about approved MBC therapies in the US, Canada, Europe and Australia, symptom and side effect mitigation, cutting-edge research, and more. If you like the way the SABCS information is presented and want to start the New Year armed with science-based MBC information, please visit insidersguidembc.com/
To access the SABCS 2020 recap, please visit: insidersguidembc.com/sabcs
Thank you, and happy New Year!
Anne